RETINAL ANGIOMATOUS PROLIFERATION CASE REPORT

Insights

Rapidly progressive (RAP) and age-related macular degeneration (AMD) share diagnostic similarities. A single intravitreal injection of Triamcinolone Acetonide (IVTA) significantly improved vision and resolved macular edema in a patient with RAP.

Area of Science:

  • Ophthalmology
  • Retinal Diseases

Background:

  • Distinguishing between rapidly progressive (RAP) and age-related macular degeneration (AMD) is crucial, though they share diagnostic similarities.
  • RAP is often characterized by the presence of pigment epithelial detachment (PED), exudates, and superficial hemorrhages, which are less common in AMD.

Observation:

  • A 75-year-old male presented with a 4-month history of vision loss in his right eye.
  • Ophthalmic examination revealed significantly reduced visual acuity (VA) in the right eye (4/50 uncorrected) compared to the left (5/5 corrected).
  • Fundus angiography (FA) and optical coherence tomography (OCT) of the right eye showed intraretinal neovascularization, subretinal, and intraretinal fluid.

Findings:

  • A single intravitreal injection of Triamcinolone Acetonide (IVTA) was administered to the affected right eye.
  • One week post-injection, the patient's VA improved to 5/30.
  • Macular edema gradually resolved within one month following the IVTA treatment, as confirmed by OCT.

Implications:

  • Despite late presentation, a single IVTA injection demonstrated significant efficacy in improving VA and resolving macular edema in RAP.
  • This case highlights the potential of IVTA as a treatment option for rapidly progressive (RAP).
  • Early diagnosis and prompt treatment are essential for better outcomes in retinal vascular diseases.

Related Concept Videos